Hyperlipidemia Drugs Market Size, Share, Growth and Industry Report

<p>The global hyperlipidemia drugs market size reached USD 23.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.2 Billion by 2033, exhibiting a growth rate (CAGR) of 1.69% during 2025-2033.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left">Report Attribute&nbsp;</div>
</th>
<th scope="col">
<div style="text-align:left">Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>
<div>2024</div>
</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2025-2033</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2019-2024</div>
</td>
</tr>
<tr>
<td>
<div><strong>Market Size in 2024</strong></div>
</td>
<td>USD 23.1&nbsp;Billion</td>
</tr>
<tr>
<td>
<div><strong>Market Forecast in 2033</strong></div>
</td>
<td>USD&nbsp;27.2Billion</td>
</tr>
<tr>
<td><strong>Market Growth Rate (2025-2033)</strong></td>
<td>1.69%</td>
</tr>
</tbody>
</table>

<p style="text-align:justify">IMARC Group provides an analysis of the key trends in each sub-segment of the global hyperlipidemia drugs&nbsp;market&nbsp;report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on drug type and end user.</p>

<p>全球高脂血症药物市场规模于2024年达到2310亿美元。展望未来，IMARC集团预计该市场将在2033年达到2720亿美元，在2025年至2033年期间呈现1.69%的复合年增长率。</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left">报告属性</div>
</th>
<th scope="col">
<div style="text-align:left">关键统计数据</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>基准年份</strong></div>
</td>
<td>
<div>2024</div>
</td>
</tr>
<tr>
<td>
<div><strong>预测年份</strong></div>
</td>
<td>
<div>2025-2033</div>
</td>
</tr>
<tr>
<td>
<div><strong>历史年份</strong></div>
</td>
<td>
<div>2019-2024</div>
</td>
</tr>
<tr>
<td>
<div><strong>2024年市场规模</strong></div>
</td>
<td>2310亿美元</td>
</tr>
<tr>
<td><strong>2033年市场规模预测</strong></td>
<td>2720亿美元</td>
</tr>
<tr>
<td><strong>2025-2033年市场增长率</strong></td>
<td>1.69%</td>
</tr>
</tbody>
</table>

<p style="text-align:justify">IMARC集团对全球高脂血症药物市场的各个子市场的主要趋势进行了分析，并提供了2025-2033年全球、区域和国家层面的预测。本报告根据药物类型和终端用户对市场进行了分类。</p>